Related Experiment Video

Updated: Jun 16, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.6K

Correction: LRG1 as a novel therapeutic target in eye disease

Giulia De Rossi1, Marlene E Da Vitoria Lobo2, John Greenwood2

  • 1Institute of Ophthalmology, University College London, 11-43 Bath Street, London, EC1V 9EL, UK. giulia.derossi@ucl.ac.uk.

Eye (London, England)
|March 1, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.3K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.4K

Related Experiment Videos

Last Updated: Jun 16, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.6K
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.3K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.4K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Articles linked to this work by shared authors, journal, and citation graph.

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026

Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in mice.

Science translational medicine·2025

LRG1 Alters Pericyte Phenotype and Compromises Vascular Maturation.

Cells·2025

Daily Light Onset and Plasma Membrane Tethers Regulate Mitochondria Redistribution within the Retinal Pigment Epithelium.

Cells·2024

Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial.

Blood·2023

Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease.

Cells·2022

Retinal detachment complicating ocular coloboma.

Eye (London, England)·2026

Transition from intermediate to late AMD and associated changes in vision by two years in a multicentre cohort study in Europe- INTERCEPT-AMD Report 3.

Eye (London, England)·2026

Timing of corticosteroid-sparing therapies in non-infectious uveitis: a population-based cohort study from Denmark.

Eye (London, England)·2026

Incidence and risk factors for retinopathy of prematurity: A hospital-based study in Iran.

Eye (London, England)·2026

Teprotumumab Effects on Thyroid Eye Disease in a Japanese MRI Study: Comparison with Intravenous Glucocorticoid Therapy.

The Journal of clinical endocrinology and metabolism·2026

Research progress in the clinical application of AI in strabismus.

Strabismus·2026

Distance-dependent changes in deviation control after alternate occlusion therapy in children with intermittent exotropia: a retrospective pilot study.

Strabismus·2026

Assessment of the Optic Nerve Sheath Diameter by Bedside Sonography and Its Correlation With the Glasgow Coma Score in the Outcome of Patients With Sepsis-Associated Encephalopathy.

Cureus·2026

Enzymatic glycosylation as a potential molecular link between Alzheimer's disease and glaucoma.

International journal of ophthalmology·2026

Diagnostic value of urinary albumin creatinine ratio in predicting vision-threatening diabetic retinopathy in patients with diabetes: a systematic review and Meta-analysis.

International journal of ophthalmology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us